Sleep Medicine Reviews
Volume 13, Issue 2 , Pages 149-156, April 2009

Diagnosis and management of restless legs syndrome in children

  • Narong Simakajornboon

      Affiliations

    • Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
  • ,
  • Leila Kheirandish-Gozal

      Affiliations

    • Kosair Children Hospital Research Institute, Division of Pediatric Sleep Medicine, University of Louisville, 570 S. Preston Street, Suite 204, Louisville, KY 40202, USA
  • ,
  • David Gozal

      Affiliations

    • Kosair Children Hospital Research Institute, Division of Pediatric Sleep Medicine, University of Louisville, 570 S. Preston Street, Suite 204, Louisville, KY 40202, USA
    • Corresponding Author InformationCorrespondence to: David Gozal, Department of Pediatrics, Comer Children's Hospital, The University of Chicago, 5721 S. Maryland Avenue, MC 8000, Suite K-160, Chicago, IL 60637, USA. Tel.: +1 (773) 834 1483; fax: +1 (773) 702 4523.

Summary 

Recent published evidence suggests that restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are common condition in children and adolescents. It is likely that if left untreated, RLS and PLMD may lead to adverse cardiovascular and neurocognitive consequences. However, the diagnosis of RLS and PLMD in children is challenging, particularly because children are relatively unable to describe typical RLS symptoms. The International Restless Legs Study Group has recently published consensus criteria for the diagnosis of RLS and PLMD in children. In addition to clinical description of RLS symptoms, supportive evidence including the presence of clinical sleep disturbances, documented periodic limb movements in sleep from overnight sleep study and family history of restless legs syndrome may be required. Few if any controlled studies have addressed the management of RLS and PLMD, which may involve both non-pharmacologic and pharmacologic approaches. In this context, the importance of avoidance of aggravating factors and good sleep hygiene cannot be overemphasized. Children with evidence of low-iron storage, i.e., low-serum ferritin and/or iron levels may likely benefit from iron therapy. While there is overall limited experience regarding the use of dopaminergic agents in children with RLS and PLMD, published reports suggesting efficacy of compounds such as levodopa, ropinirole, pramipexole and pergolide have emerged. Other medications including benzodiazepine, anti-convulsants, alpha-adrenergic and opioid medications have not been adequately studied in children. Children with RLS and PLMD should have regular follow-up visits to evaluate clinical improvement and to monitor adverse effects from the selected therapy. Based on aforementioned findings, it is clear that a substantial research effort is needed to evaluate the pathophysiology, clinical presentation, treatment modalities, and overall long-term outcome of children with RLS and PLMD.

Keywords: Restless legs syndrome, Periodic limb movement disorder, Dopaminergic medications, Iron therapy, Children, Attention-deficit hyperactivity disorder

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1087-0792(08)00131-7

doi:10.1016/j.smrv.2008.12.002

Sleep Medicine Reviews
Volume 13, Issue 2 , Pages 149-156, April 2009